-+ 0.00%
-+ 0.00%
-+ 0.00%

Mereo BioPharma Group Q2 EPS $(0.01), Inline

Benzinga·08/11/2026 12:17:03
Listen to the news
Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.